Pharmaceutical Industry Analysis and Statistics (since 2008

In BMI?s Business Environment Ranking matrix for Q209, Latvia is found in a lowly 17th position, out ofthe 20 markets surveyed in Central and Eastern Europe (CEE). In relation to the previous quarter,Latvia?s placement worsened considerably; due to its small and falling population numbers that limit ...

Industries : Healthcare, Pharmaceutical

Lebanon Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

Lebanon?s pharmaceutical market was worth US$500mn in 2008, and is expected to grow to be worthUS$517mn in 2009. It is further expected to reach US$605mn by 2013, representing a CAGR of 3.95%.Before the country's civil war, which ended in 1990, Lebanon had one of the strongest pharmaceuticalindustri ...

Industries : Healthcare, Pharmaceutical

Malaysia Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

In the BMI Business Environment Ranking matrix for Q209, Malaysia returned to eight position (from tenthpreviously), out of the 15 key regional markets surveyed in the Asia Pacific region. Key attractions of theMalaysian pharmaceutical market are the government?s encouragement of the biotechnology s ...

Industries : Healthcare, Pharmaceutical

Mexico Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

For this Q209 update of Mexico?s Pharmaceutical and Healthcare report, we have updated our forecastextending through to 2013. Over the next five years, we expect total drug market spending to increasefrom US$13.48bn in 2008 to US$27.33bn by 2013, representing a compound annual growth rate (CAGR)of 1 ...

Industries : Healthcare, Pharmaceutical

Philippines Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

The Philippines continued to be ranked as the 11th most attractive pharmaceutical market in the AsiaPacific region, according to BMI?s Business Environment Rankings for Q209. Nevertheless, BMIexpects the country to somewhat improve this position over the next five-year period as the marketmatures, w ...

Industries : Healthcare, Pharmaceutical

Portugal Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

The Portugal Pharmaceuticals & Healthcare Report Q2 2009 is the latest addition to BMI's IndustrySurvey & Forecasts Series. The value of the country?s pharmaceutical market is forecast to reachUS$5.42bn by 2013, representing a compound annual growth rate (CAGR) of 1.34%. However, thistopline project ...

Industries : Healthcare, Pharmaceutical

Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

BMI forecasts that total pharmaceutical spending in Saudi Arabia will increase from US$2.65bn in 2008to US$3.68bn by 2013, representing a compound annual growth rate of 6.8% in US dollar terms. Webelieve that the main drivers for growth will be the increasing burden of respiratory diseases in thecou ...

Industries : Healthcare, Pharmaceutical

Singapore Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

In BMI?s Business Environment Rankings (BER) matrix for Q209, Singapore retained its respectablefourth position out of the 15 key countries in the region, behind only the three most developedpharmaceutical markets in the region, namely Japan, Australia and South Korea. Positives include a 100%urban ...

Industries : Healthcare, Pharmaceutical

Slovakia Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

Slovakia?s pharmaceutical market will represent sound prospects for multinational pharmaceuticalcompanies over the next five years. Despite relatively mediocre total sales of US$2.04bn in 2008, percapita spending has been strong, averaging double-digit growth over the past four years.Following euroz ...

Industries : Healthcare, Pharmaceutical

United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

The United Arab Emirates (UAE) has retained its pole position in BMI?s Q209 Business EnvironmentRankings for the 17 key markets within the Middle East and Africa (MEA) region. Globally, the UAE isranked eighteenth, and is thus comparable to some developed European markets. This high rankingillustrat ...

Industries : Healthcare, Pharmaceutical

United States Pharmaceuticals and Healthcare Report Q2 2009

$ 495
April 2009

The US pharmaceutical market is the largest in the world and, accordingly, it has the world?s highest percapita drug spending ? currently US$1,031. This figure is, however, forecast to fall to just US$950 by2013, changing at a compound annual growth rate (CAGR) of -1.62%. The total market, valued at ...

Industries : Healthcare, Pharmaceutical

Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth

$ 11 400
April 2009

IntroductionBPH is a chronic urological condition involving the non-cancerous enlargement of the prostate affecting over 15 million men across the seven major markets. The market for BPH drugs that aim to alleviate the symptoms and reduce prostate size was worth $3.7bn in 2008. The BPH market is exp ...